AGMB Company Profile and Key Details

NASDAQ : AGMB

AgomAb Therapeutics NV American Depositary Shares

$13.25

-0.18-1.34%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) stock declined over -1.34%, trading at $13.25 on NASDAQ, down from the previous close of $13.43. The stock opened at $13.50, fluctuating between $13.07 and $13.64 in the recent session.

Stock Snapshot

13.43

Prev. Close

652.54M

Market Cap

13.065

Day Low

-0.29

P/E Ratio

-46.11015

EPS (TTM)

N/A

Cash Flow per Share

13.5

Open

49.25M

Number of Shares

13.64

Day High

N/A

Free Float in %

N/A

Book Value

68.05K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 21, 2026	13.50	13.64	13.07	13.25	68.36K
Aug 20, 2026	13.74	13.85	13.01	13.43	92.23K
Aug 19, 2026	13.81	14.42	13.59	13.75	137.39K
Aug 18, 2026	13.62	13.86	13.42	13.73	30.87K
Aug 17, 2026	13.25	13.90	13.02	13.68	119.26K
Aug 14, 2026	14.03	14.03	13.03	13.22	41.98K
Aug 13, 2026	14.24	14.29	13.75	13.95	241.58K
Aug 12, 2026	14.85	15.58	13.80	14.11	151.42K
Aug 11, 2026	15.10	15.50	14.53	14.85	60.99K
Aug 10, 2026	14.53	15.44	13.64	15.00	87.44K
Aug 07, 2026	13.62	14.50	13.15	14.50	367.4K
Aug 06, 2026	14.44	14.50	13.31	13.50	38.63K
Aug 05, 2026	14.91	14.91	14.16	14.32	29.06K
Aug 04, 2026	13.75	14.87	13.67	14.73	87.37K
Aug 03, 2026	12.63	13.52	12.41	13.52	126.05K
Jul 31, 2026	12.76	13.00	12.26	12.87	54.09K
Jul 30, 2026	12.66	13.16	12.19	12.76	68.9K
Jul 29, 2026	12.54	13.42	12.10	12.40	46.77K
Jul 28, 2026	12.68	12.93	12.07	12.54	33.03K
Jul 27, 2026	12.56	13.16	12.31	12.51	33.4K

Contact Details

Antwerp, VL 2600

Belgium

https://agomab.com 323 318 9170

About Company

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, particularly chronic fibrotic conditions where significant unmet medical needs persist. Its innovative pipeline features several promising candidates, including Ontunisertib (AGMB-129), an orally administered, gastrointestinal-restricted small molecule inhibitor targeting ALK5 or TGFßR1, designed to treat Fibrostenosing Crohn's disease and presently undergoing Phase 2a clinical trials. Also in development is AGMB-447, an inhaled small molecule that similarly inhibits ALK5 or TGFßR1, intended for idiopathic pulmonary fibrosis and currently in Phase 1 clinical studies. Furthermore, the company is advancing AGMB-101, a monoclonal antibody designed to mimic HGF. This agent exerts its effects through the agonism or stimulation of the MET receptor, having demonstrated both antifibrotic and regenerative capabilities in preclinical models. Established in 2017, AgomAb Therapeutics maintains its headquarters in Antwerp, Belgium.

Stock Peers

ARGX

1.66+0.16%

argenx SE$1,039.78 REGN

7.4+0.90%

Regeneron Pharmaceuticals, Inc.$834.04 VRTX

7.79+1.44%

Vertex Pharmaceuticals Incorporated$548.05 MDGL

-2.35-0.45%

Madrigal Pharmaceuticals, Inc.$516.74 UTHR

-7.88-1.51%

United Therapeutics Corporation$513.12 PRAX

11.36+3.12%

Praxis Precision Medicines, Inc.$375.94 ONC

5.31+1.44%

BeOne Medicines AG$374.47 KRYS

9.56+2.84%

Krystal Biotech, Inc.$346.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-1.1-0.38%

Ligand Pharmaceuticals Incorporated$286.29

Frequently Asked Questions

What is the current AgomAb Therapeutics N.V. American Depositary Shares (AGMB) stock price?

AgomAb Therapeutics N.V. American Depositary Shares (NASDAQ: AGMB) stock price is $13.25 in the last trading session. During the trading session, AGMB stock reached the peak price of $13.64 while $13.07 was the lowest point it dropped to. The percentage change in AGMB stock occurred in the recent session was -1.34% while the dollar amount for the price change in AGMB stock was - $0.18.

AGMB's industry and sector of operation?

The NASDAQ listed AGMB is part of Biotechnology industry that operates in the broader Healthcare sector. AgomAb Therapeutics N.V. American Depositary Shares designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AGMB?

No Data

How AGMB did perform over past 52-week?

AGMB's closing price is 51.43% higher than its 52-week low of $8.75 where as its distance from 52-week high of $17.82 is -25.64%.

How many employees does AGMB have?

Number of AGMB employees currently stands at 62.

Link for AGMB official website?

Official Website of AGMB is: https://agomab.com

How do I contact AGMB?

AGMB could be contacted at phone 323 318 9170 and can also be accessed through its website. AGMB operates from Posthoflei 1/6, Antwerp, VL 2600, Belgium.

How many shares of AGMB are traded daily?

AGMB stock volume for the day was 68.05K shares. The average number of AGMB shares traded daily for last 3 months was 100.68K.

What is the market cap of AGMB currently?

The market value of AGMB currently stands at $652.54M with its latest stock price at $13.25 and 49.25M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	62
Beta	1.64
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	62
Beta	1.64
Sales or Revenue	N/A
5Y Sales Change%	N/A
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

AGMB Company Profile and Key Details

AgomAb Therapeutics NV American Depositary Shares

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Technical Performance

Dividend & Fair Value

Key Takeaways

Price Forecast & Outlook

Company Overview

Valuation Metrics